 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Myriad RBM Inks Deal with Bio-Rad to Develop and Sell Immunoassay Kits
July 27, 2012
Myriad RBM Inks Deal with Bio-Rad to Develop and Sell Immunoassay Kits
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Myriad RBM Teams with Spinal Muscular Atrophy Foundation on Protein Marker Panel
April 6, 2012 / ProteoMonitor - Affymetrix's eBio Business Moving FlowCytomix Assays to Luminex Platform, Planning New Product Combinations
April 2, 2013 / BioArray News - Ayoxxa Closes on $4M in Funding to Continue Developing Label-Free Bead Array Platform
January 25, 2013 / ProteoMonitor - Q&A: SciLifeLab's Peter Nilsson Relies on 'Unique Array Set Up' to Screen the Human Protein Atlas
October 30, 2012 / BioArray News - Genomics, Proteomics Tools Users Expect to Benefit as Sweden Pledges $320M to Life Sciences
September 11, 2012 / BioArray News